GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (OTCPK:EAPIF) » Definitions » Current Deferred Revenue

EAPIF (Euroapi) Current Deferred Revenue : $0.0 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Euroapi's current deferred revenue for the quarter that ended in Dec. 2024 was $0.0 Mil.

Euroapi Current Deferred Revenue Historical Data

The historical data trend for Euroapi's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Current Deferred Revenue Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Euroapi Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Euroapi's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Euroapi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (OTCPK:EAPIF) » Definitions » Current Deferred Revenue
Comparable Companies
XPAR:AB XPAR:BOI XPAR:ALRPD XPAR:MLCOT XPAR:VETO ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR
Traded in Other Exchanges
0EAP:UK EAPI:France 940:Germany
Address
15 rue Traversiere, Paris, FRA, 75012
Website
https://www.euroapi.com
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.